Activities of Cytochrome P450 Enzymes in Liver and Kidney Microsomes from Systemic Carnitine Deficiency Mice with a Gene Mutation of Carnitine / Organic Cation Transporter

スポンサーリンク

概要

• 論文の詳細を見る
• 2002-03-29

著者

• Yamazaki Hiroshi

  Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University

• 中島 美紀

  金沢大学 大学院医学系研究科薬物代謝化学

• Nakajima Miki

  金沢大学 薬学部薬物代謝化学研究室

• 中島 美紀

  金沢大学薬学部薬物代謝化学教室

• Nakajima Miki

  Drug Metabolism And Toxicology Faculty Of Pharmaceutical Sciences Kanazawa University

• Nakajima Miki

  Faculty Of Pharmaceutical Sciences Kanazawa University

• Nakajima Miki

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• YAMAZAKI Hiroshi

  Faculty of Pharmaceutical Sciences, Kanazawa University

• IKETAKI Hitomi

  Faculty of Pharmaceutical Sciences, Kanazawa University

• SHIBATA Ayaka

  Faculty of Pharmaceutical Sciences, Kanazawa University

• YOKOI Tsuyoshi

  Faculty of Pharmaceutical Sciences, Kanazawa University

• 中島 美紀

  金沢大学大学院医学系研究科:金沢大学大学院薬学部

• 中島 美紀

  金沢大学大学院医学系研究科

• Shibata Ayaka

  Faculty Of Pharmaceutical Sciences Kanazawa University

• Yokoi Tsuyoshi

  Division Of Drug Metabolism And Toxicology Faculty Of Pharmaceutical Sciences Kanazawa University

• Iketaki Hitomi

  Faculty Of Pharmaceutical Sciences Kanazawa University

• Yokoi Tsuyoshi

  Faculty Of Pharmaceutical Sciences Kanazawa University

関連論文

• Genotoxic Activation of the Environmental Pollutant 3-Nitrobenzanthrone by Human Cytochrome P450 Enzymes Expressed in Salmonella typhimurium umu Tester Strains
• Human blood concentrations of dichlorodiphenyltrichloroethane (DDT) extrapolated from metabolism in rats and humans and physiologically based pharmacokinetic modeling
• ラット小腸におけるP450およびグルクロン酸転移酵素の触媒活性:反転腸管とミクロソームの比較
• 抗糖尿病薬トログリタゾンの新規キノンエポキシド代謝物の同定と細胞障害性
• ヒトCYP1ファミリーの細胞特異的な誘導機構について
• ヒト肝ミクロソームのアミトリプチリンN-脱メチル化酵素活性のアルブミンによる促進作用
• テガフールからの5-フルオロウラシル生成におけるヒト肝P450およびチミジンホスホリラーゼの関与
• ヒトP450/P450還元酵素共発現系の触媒活性に及ぼすチトクロムb_5の影響
• ヒト肝P450によるフェニトインからのジヒドロキシ体生成活性に対するカタラーゼの促進効果
• トログリタゾンの代謝と肝細胞障害性の検討
• ◇◇ミニレビュー◇◇(平成11年度 日本薬物動態学会年会シンポジウムより) ヒト組換えP450酵素と肝ミクロソームを用いた薬物代謝反応におけるP450の役割の研究
• 肝P450等の薬物代謝酵素活性を指標とした日本発新規ヒト型モデル動物"マイクロミニブタ"の非臨床試験における高い将来性
• 日本人肝におけるフラビン含有モノオキシゲナーゼ3発現の個人差 : 肝転写因子との相関
• Complex Mechanism Underlying Transcriptional Control of the Haplotyped Flavin-containing Monooxygenase 3 (FMO3) Gene in Japanese : Different Regulation between Mutations in 5'-Upstream Distal Region and Common Element in Proximal Region
• 降圧薬の内服により Phenocopy 現象をきたした1例
• 日本人成人におけるチトクローム P450遺伝子多型解析に対する検討
• R- 及び S-メホバルビタールの N-脱メチル化におけるヒト CYP2B6 の関与
• 高気圧酸素療法を施した患者の抗がん薬カルボプラチン血漿中濃度測定用HPLC法について
• Phenotyping と Genotyping の臨床的意義
• Drug metabolism and toxicity in chimeric mice with humanized liver
• Missense and Nonsense Mutations of the Flavin-containing Monooxygenase 3 Gene in a Japanese Cohort
• Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
• 日本人トリメチルアミン尿症の原因となるフラビン含有モノオキシゲナーゼ3遺伝子の新規遺伝子変異
• Two Novel Single Nucleotide Polymorphisms (SNPs) of the FMO3 Gene in Japanese
• Human Blood Concentrations of Dichlorodiphenyltrichloroethane (DDT) Extrapolated from Metabolism in Rats and Humans and Physiologically Based Pharmacokinetic Modeling
• Microminipig, a Non-rodent Experimental Animal Optimized for Life Science Research:In Vivo Proarrhythmia Models of Drug-Induced Long QT Syndrome: Development of Chronic Atrioventricular Block Model of Microminipig
• モルヒネのグルクロン酸抱合阻害による薬物相互作用の予測
• Urinary Excretion of Phenytoin Metabolites, 5-(4'-hydroxyphenyl)-5-Phenylhydantoin and its O-glucuronide in Humans and Analysis of Genetic Polymorphisms of UDP-glucuronosyltransferases
• Drug Metabolism and Toxicity in Chimeric Mice with Humanized Liver
• Immunohistochemical analysis of CYP2A13 in various types of human lung cancers
• チトクロームP450の遺伝子多型:CYP1A1,1A2,1B1,2D6,2E1 (特集 チトクロームP450遺伝子多型)
• ヒトCYP1A2の遺伝子変異と発がんリスクとの関連
• Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes(Biopharmacy)
• Characterization of a Novel Variant (S145C/L311V) of 3α-Hydroxysteroid/Dihydrodiol Dehydrogenase in Human Liver.
• Pharmacokinetic Investigation of Increased Efficacy Against Malignant Gliomas of Carboplatin Combined With Hyperbaric Oxygenation
• ヒト肝におけるニコチンおよびコチニンの代謝
• 2B-08 Establishment of Genetically Engineered E.coli Highly Sensitive to Nitrosamines by Introducing Human CYP2E1
• Twenty One Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2A6 Gene in Japanese and Caucasians
• Activities of Cytochrome P450 Enzymes in Liver and Kidney Microsomes from Systemic Carnitine Deficiency Mice with a Gene Mutation of Carnitine / Organic Cation Transporter
• CYP3A5 Contributes Significantly to CYP3A-mediated Drug Oxidations in Liver Microsomes from Japanese Subjects
• In vivo Evaluation of Coumarin and Nicotine as Probe Drugs to Predict the Metabolic Capacity of CYP2A6 Due to Genetic Polymorphism in Thais
• Novel Nonsynonymous Polymorphisms of the CYP1A1 Gene in Japanese
• Toxicological roles of human and rodent CYP2As in the mutagenic activation of N-nitrosamines.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
• Novel Mutations of the CYP2A6 Gene in a Thai Population with Lowered Capacity of Coumarin 7-Hydroxylation
• Genetic Polymorphism in the 5'-Flanking Region of Human CYP1A2 Gene : Effect on the CYP1A2 Inducibility in Humans
• Two Novel Haplotypes of CYP2D6 Gene in a Japanese Population
• Eighteen Novel Polymorphisms of the CYP2A13 Gene in Japanesse
• Metabolic Activation of Dimethylnitrosamine(DMN) by Human CYP2E1 Expressed in O^6-Methylguanine-DNA Methyltransferase-Deficient Cells
• EXPRESSION OF RECOMBINANT HUMAN CYTOCHROME P450 (P450 OR CYP) 2A6 IN ESCHERICHIA COLI.
• "S2-3 STRATEGIC PROPOSALS TO AVOID TOXIC DRUG INTERACTIONS DURING NEW DRUG DEVELOPMENT : MOLECULAR TOXICOLOGY PROPOSALS (Strategy how we can learn drug-drug interaction during the development of a new drug)
• Stable expression of CYP3A4 and CYP3A7, adult and fetal-specific forms of cytochrome P450 in human liver, in CHL cells and its application to toxicological testing.
• 抗がん薬のファーマコジェネティクス
• 抗がん薬のファーマコジェネティクス
• ニコチン代謝とCYP2A6の遺伝子多型
• S5-2 抗癌薬の代謝・副作用と遺伝子多型 : 臨床適用にむけた基礎研究の現状(遺伝子診断の臨床適用の現状,医療薬学の扉は開かれた)
• 平成16年度日本薬物動態学会奨励賞を受賞して
• ニコチン代謝とCYP2A6
• ヒトCYP1B1の転写調節機構 : 発がんとエストロゲンのホメオスタシス
• 喫煙とCMP2A6の遺伝子多型 (6月第1土曜特集 ファーマコゲノミクスとテーラーメイド医療) -- (臨床への応用)
• 癌の遺伝子治療とチトクロムP450
• ヒトCYP1A2の遺伝子多型と人種差に関する研究
• Blood Concentrations of 1,4-Dioxane in Humans after Oral Administration Extrapolated from In Vivo Rat Pharmacokinetics, In Vitro Human Metabolism, and Physiologically Based Pharmacokinetic Modeling
• Comparison of the Contributions of Cytochromes P450 3A4 and 3A5 in Drug Oxidation Rates and Substrate Inhibition
• Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor
• Thiopurine Methyltransferase Genotype and Phenotype Status in Japanese Patients with Systemic Lupus Erythematosus(Biopharmacy)
• AN ENZYMIC MECHANISM FOR MUTAGENIC ACTIVATION OF CARCINOGENIC AMINOAZO DYES
• In silico および in vitro 技術を用いたヒトUDP-グルクロン酸転移酵素(UGT)1A9熱安定性の解析
• Binding of Steroidogenic Factor-1 to the Regulatory Region Might Not Be Critical for Transcriptional Regulation of the Human CYP1B1 Gene
• Critical Enhancer Region to Which AhR/ARNT and Sp1 Bind in the Human CYP1B1 Gene
• ディスポーザ排水処理システムにおける負荷特性と微小動物相・浄化機能との関係解析
• Species Difference between Cynomolgus Monkeys and Humans on Cytochromes P450 2D and 3A-Dependent Drug Oxidation Activities in Liver Microsomes
• Bonitos with Low Content of Malodorous Trimethylamine as Palliative Care for Self-reported Japanese Trimethylaminuria Subjects
• Desieg and Synthesis of para-Fluorophenylalanine Amide Derivatives as Thrombin Receptor Antagonists
• Interaction Mode of the Phe-Phenyl Group of Thrombin Receptor-Tethered Ligand SFLLRNP in Receptor Activation
• The Role of Arginine in Thrombin Receptor Tethered-Ligand Peptide in Intramolecular Receptor Binding and Self-Activation
• Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system(CELL AND TISSUE ENGINEERING)
• Inhibitory Effects of Kampo Medicine on Human UGT2B7 Activity
• Platelet Aggregation Activity of Thrombin Receptor-Tethered Peptide Ligand Containing Free Thiol or Activated SH Group
• Design and Synthesis of para-Fluorophenylalanine Amide Derivatives Containing N-Terminal Thiol as Thrombin Receptor Antagonist
• Cynomolgus Macaque CYP4 Isoforms Are Functional, Metabolizing Arachidonic Acid
• Dose-dependent Effects of Cigarette Smoke on Blood Biomarkers in Healthy Japanese Volunteers : Observations from Smoking and Non-smoking
• Acetaminophen-induced changes of gene expression in rat liver (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Identification and Characterization of CYP2C18 in Cynomolgus Macaque (Macaca fascicularis)
• Identification and Characterization of CYP2B6 cDNA in Cynomolgus Macaques (Macaca fascicularis)
• Induction of Human CYP1A2 and CYP3A4 in Primary Culture of Hepatocytes from Chimeric Mice with Humanized Liver
• 教育・研究・医療機関編(2) : 新しい展開を模索して
• Update on Prediction of Drug Metabolizing Enzyme- and Transporter-based Drug Interactions
• Evaluation of Human CYP1A2 and CYP3A4 mRNA Expression in Hepatocytes from Chimeric Mice with Humanized Liver
• Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies
• 薬物動態と microRNA
• Evaluation of cytotoxic potential of cored soft contact lenses with adsorbed active ingredients from over-the-counter eye drops
• Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models
• Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor
• Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4

もっと見る 閉じる

スポンサーリンク